M. J. Alter, Epidemiology of hepatitis C virus infection, World Journal of Gastroenterology, vol.13, issue.17, pp.2436-2441, 2007.

M. A. Blomé, P. Björkman, L. Flamholc, H. Jacobsson, V. Molnegren et al., Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program, Journal of Viral Hepatitis, vol.18, issue.12, pp.831-839, 2011.

A. Bowers, K. Cleverley, C. Di-clemente, and J. Henderson, Transitional-aged youth perceptions of influential factors for substance-use change and treatment seeking, Patient Preference and Adherence, vol.11, pp.1939-1948, 2017.

L. Boyer, Le coeur à l' ouvrage, Human Sciences, vol.92, pp.20-23, 1999.

M. P. Carrieri, C. Leport, C. Protopopescu, J. P. Cassuto, E. Bouvet et al.,

B. Spire, Factors associated with nonadherence to highly active antiretroviral therapy: A 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase, Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-485, 2006.

M. P. Carrieri, P. Roux, J. Cohen, I. Ravaux, P. Dellamonica et al.,

A. Rosenblum, Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: Results from the MANIF 2000 cohort study, Addiction, issue.12, pp.2160-2168, 2010.

H. M. Colón, R. R. Robles, S. Deren, H. Sahai, H. A. Finlinson et al., Between-city variation in frequency of injection among Puerto Rican injection drug users, Journal of Acquired Immune Deficiency Syndromes, vol.27, issue.4, pp.405-413, 2001.

P. R. Danzinger and E. R. Welfel, Age, gender and health bias in counselors: An empirical analysis, Journal of Mental Health Counseling, vol.22, issue.2, pp.135-149, 2000.

P. De, J. Cox, J. Boivin, R. W. Platt, and A. M. Jolly, Rethinking approaches to risk reduction for injection drug users: Differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks, JAIDS Journal Of Acquired Immune Deficiency Syndromes, vol.46, issue.3, pp.355-361, 2007.

E. L. Deci and R. M. Ryan, Intrinsic motivation and self-determination in human behavior, 1985.

J. Emmanuelli and J. C. Desenclos, Harm reduction interventions, behaviors and associated health outcomes in France, Addiction, vol.100, issue.11, pp.1690-1700, 1996.

C. L. Fry and N. Lintzeris, Best practices: treatment and rehabilitation for seniors with substance use problems (Publication No. H46-2/03-295F), Health Canada, vol.98, issue.2, pp.171-178, 2002.

M. Jauffret-roustide, J. Pillonel, L. Barillet, L. Leon, Y. Le-strat et al.,

C. Semaille, Estimation of HIV and hepatitis C prevalence among drug users in France -first results from the ANRS-Coquelicot, Survey. Bulletin Epidemiologique Hebdomadaire, pp.504-509, 2011.

A. H. Kral, J. Lorvick, and B. R. Edlin, Sex-and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco, Journal of Acquired Immune Deficiency Syndromes, vol.24, issue.2, pp.162-167, 2000.

L. Marchand, C. Evans, J. Page, K. Davidson, P. J. Hahn et al., Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug and Alcohol Dependence, vol.127, pp.143-149, 2013.

C. Levesque, G. C. Williams, D. Elliot, M. A. Pickering, B. Bodenhamer et al., Validating the theoretical structure of the treatment self-regulation questionnaire (TSRQ) across three different health behaviors, Health Education Research, vol.22, issue.5, pp.691-702, 2007.

E. Lloyd-smith, E. Wood, R. Zhang, M. W. Tyndall, S. Sheps et al., Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: A cohort study, BMC Public Health, vol.10, issue.1, 2010.

L. Maher, B. Jalaludin, K. G. Chant, R. Jayasuriya, T. Sladden et al., Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, vol.101, issue.10, pp.1499-1508, 2006.

S. S. Mahmoodabad, N. R. Tonekaboni, R. Farmanbar, H. Fallahzadeh, and T. Kamalikhah, The effect of motivational interviewing-based intervention using self-determination theory on promotion of physical activity among women in reproductive age: A randomized clinical trial, Electron Physician, vol.9, issue.5, pp.4461-4472, 2017.

L. S. Miller and R. H. Gramzow, A self-determination theory and motivational interviewing intervention to decrease racial/ethnic disparities in physical activity: Rationale and design, vol.16, p.768, 2016.

W. Miller and S. Rollnick, Motivational interwiewing: Preparing people to change addictive behaviour, 1991.

S. B. Montgomery, J. Hyde, C. J. De-rosa, L. A. Rohrbach, S. Ennett et al.,

M. D. Kipke, Gender differences in HIV risk behaviors among young injectors and their social network members, The American Journal of Drug and Alcohol Abuse, vol.28, issue.3, pp.453-475, 2002.

N. Palmateer, S. Hutchinson, G. Mcallister, A. Munro, S. Cameron et al., Risk of transmission associated with sharing drug injecting paraphernalia: Analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data, Journal of Viral Hepatitis, vol.21, issue.1, pp.25-32, 2014.

G. C. Williams, H. Patrick, C. P. Niemiec, R. M. Ryan, E. L. Deci et al., The Smoker's Health Project: A self-determination theory intervention to facilitate maintenance of tobacco abstinence, Contemporary Clinical Trials, vol.32, issue.4, pp.535-543, 2011.

G. C. Williams, H. Patrick, C. P. Niemiec, L. K. Williams, G. Divine et al.,

M. Pladevall, Reducing the health risks of diabetes: How self-determination theory may help improve medication adherence and quality of life, The Diabetes Educator, vol.35, issue.3, pp.484-492, 2009.

G. G. Williams, M. Gagné, R. M. Ryan, and E. L. Deci, Facilitating autonomous motivation for smoking cessation, Health Psychology, vol.21, issue.1, pp.40-50, 2002.